Wall Street brokerages forecast that Healthequity Inc (NASDAQ:HQY) will report earnings per share of $0.19 for the current quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Healthequity’s earnings. The lowest EPS estimate is $0.15 and the highest is $0.23. Healthequity reported earnings of $0.27 per share in the same quarter last year, which suggests a negative year-over-year growth rate of 29.6%. The business is expected to issue its next quarterly earnings report on Monday, March 16th.
According to Zacks, analysts expect that Healthequity will report full year earnings of $1.42 per share for the current fiscal year, with EPS estimates ranging from $1.15 to $1.52. For the next financial year, analysts anticipate that the firm will report earnings of $1.59 per share, with EPS estimates ranging from $0.93 to $2.00. Zacks’ EPS averages are a mean average based on a survey of sell-side research firms that that provide coverage for Healthequity.
Healthequity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, December 3rd. The company reported $0.47 EPS for the quarter, beating the consensus estimate of $0.14 by $0.33. Healthequity had a return on equity of 11.31% and a net margin of 13.03%. The business had revenue of $157.12 million during the quarter, compared to analysts’ expectations of $152.38 million. During the same period last year, the firm earned $0.25 EPS. The company’s quarterly revenue was up 122.9% compared to the same quarter last year.
A number of research analysts have recently weighed in on the company. Wells Fargo & Co lowered their price target on Healthequity from $80.00 to $76.00 and set an “outperformer” rating on the stock in a report on Wednesday, September 4th. SunTrust Banks dropped their price target on shares of Healthequity to $80.00 and set a “buy” rating on the stock in a research report on Monday, September 9th. Oppenheimer decreased their price objective on shares of Healthequity from $98.00 to $76.00 and set an “outperform” rating for the company in a report on Wednesday, September 4th. Zacks Investment Research upgraded shares of Healthequity from a “sell” rating to a “buy” rating and set a $62.00 target price on the stock in a research note on Tuesday, November 5th. Finally, Barrington Research reiterated a “buy” rating and issued a $75.00 target price on shares of Healthequity in a report on Monday, December 2nd. Three investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $77.86.
In related news, CFO Darcy G. Mott sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, October 21st. The shares were sold at an average price of $56.90, for a total value of $227,600.00. Following the completion of the transaction, the chief financial officer now owns 42,000 shares in the company, valued at approximately $2,389,800. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In the last three months, insiders sold 12,000 shares of company stock valued at $715,600. 3.70% of the stock is currently owned by company insiders.
Several large investors have recently made changes to their positions in the stock. Meeder Asset Management Inc. acquired a new position in Healthequity in the second quarter valued at about $25,000. BerganKDV Wealth Management LLC acquired a new stake in shares of Healthequity in the second quarter valued at approximately $26,000. FTB Advisors Inc. bought a new stake in shares of Healthequity in the second quarter worth $27,000. Griffin Asset Management Inc. acquired a new position in Healthequity during the second quarter worth $29,000. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. bought a new stake in Healthequity during the 2nd quarter worth about $39,000. Institutional investors and hedge funds own 95.84% of the company’s stock.
NASDAQ:HQY traded up $1.89 during midday trading on Friday, hitting $67.43. 1,253,931 shares of the stock were exchanged, compared to its average volume of 650,249. The company has a market capitalization of $4.63 billion, a price-to-earnings ratio of 70.98, a P/E/G ratio of 2.26 and a beta of 1.47. The company has a current ratio of 1.91, a quick ratio of 22.98 and a debt-to-equity ratio of 1.25. Healthequity has a one year low of $50.29 and a one year high of $85.07. The business has a 50-day moving average price of $60.40 and a two-hundred day moving average price of $64.15.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Article: Monthly Dividend Stocks Can Provide Solid Income
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.